Action Therapeutics
Semiconductor ManufacturingCalifornia, United States2-10 Employees
Pelvic pain las vegas Henderson incontinence pregnancy post partum tisdale McGinn Action therapeutics.
Market Expansion Action Therapeutics has recently gone public, indicating an increased capacity for growth and investment, which presents opportunities to engage with healthcare providers and medical device distributors looking to collaborate with innovative companies in the semiconductor and medical technology sectors.
Healthcare Focus The company's specialization in pelvic pain, incontinence, and postpartum health suggests potential sales opportunities with medical practitioners, clinics, and rehabilitation centers focused on women's health and pelvic therapy solutions.
Financial Scale With a revenue range of one to ten million dollars, Action Therapeutics is positioned as a growth-stage company that may require advanced semiconductor manufacturing services or strategic partnerships to expand their technological capabilities and market reach.
Technology Stack Utilizing a range of web technologies and hosting services like Google Structured Data and Nginx shows a focus on digital presence and data optimization, which can be leveraged to offer targeted digital marketing, data management, or web infrastructure solutions to enhance their online outreach.
Competitive Landscape Operating within a competitive industry alongside companies with hundreds to thousands of employees and revenues reaching into hundreds of millions, Action Therapeutics may benefit from innovative semiconductor solutions or strategic tech collaborations to strengthen their market positioning and product development pipeline.
Action Therapeutics uses 8 technology products and services including Open Graph, oEmbed, GSAP, and more. Explore Action Therapeutics's tech stack below.
| Action Therapeutics Email Formats | Percentage |
| First@actiontherapeuticspt.com | 100% |
Semiconductor ManufacturingCalifornia, United States2-10 Employees
Pelvic pain las vegas Henderson incontinence pregnancy post partum tisdale McGinn Action therapeutics.
Action Therapeutics's revenue is estimated to be in the range of $1M
Action Therapeutics's revenue is estimated to be in the range of $1M